Krystyna Ossowska
Department of Neuro-Psychopharmacology
Institute of Pharmacology
Polish Academy of Sciences
Kraków
Poland
Name/email consistency: high
- An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats. Ossowska, K., Konieczny, J., Wardas, J., Pietraszek, M., Kuter, K., Wolfarth, S., Pilc, A. Amino. Acids (2007)
- Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease. Ossowska, K., Smiałowska, M., Kuter, K., Wierońska, J., Zieba, B., Wardas, J., Nowak, P., Dabrowska, J., Bortel, A., Biedka, I., Schulze, G., Rommelspacher, H. Neuroscience (2006)
- MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats. Ossowska, K., Konieczny, J., Wolfarth, S., Pilc, A. Neuropharmacology (2005)
- Influence of paraquat on dopaminergic transporter in the rat brain. Ossowska, K., Wardas, J., Kuter, K., Nowak, P., Dabrowska, J., Bortel, A., Labus, Ł., Kwieciński, A., Krygowska-Wajs, A., Wolfarth, S. Pharmacol. Rep (2005)
- A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?. Ossowska, K., Wardas, J., Smiałowska, M., Kuter, K., Lenda, T., Wierońska, J.M., Zieba, B., Nowak, P., Dabrowska, J., Bortel, A., Kwieciński, A., Wolfarth, S. Eur. J. Neurosci. (2005)
- Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist. Ossowska, K., Pietraszek, M., Wardas, J., Wolfarth, S. Pol. J. Pharmacol (2004)
- The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats. Ossowska, K., Wardas, J., Pietraszek, M., Konieczny, J., Wolfarth, S. Neurosci. Lett. (2003)
- Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study. Ossowska, K., Pietraszek, M., Wardas, J., Dziedzicka-Wasylewska, M., Nowicka, D., Wolfarth, S. Pol. J. Pharmacol (2002)
- The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors. Ossowska, K., Konieczny, J., Pilc, A., Wolfarth, S. Brain Res. (2002)
- The role of striatal metabotropic glutamate receptors in Parkinson's disease. Ossowska, K., Konieczny, J., Wardas, J., Gołembiowska, K., Wolfarth, S., Pilc, A. Amino. Acids (2002)
- Decline in motor functions in aging is related to the loss of NMDA receptors. Ossowska, K., Wolfarth, S., Schulze, G., Wardas, J., Pietraszek, M., Lorenc-Koci, E., Smiałowska, M., Coper, H. Brain Res. (2001)
- Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats. Ossowska, K., Konieczny, J., Wolfarth, S., Wierońska, J., Pilc, A. Neuropharmacology (2001)
- Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats. Ossowska, K., Pietraszek, M., Wardas, J., Nowak, G., Wolfarth, S. Naunyn Schmiedebergs Arch. Pharmacol. (1999)